Sabra Health Care REIT (NASDAQ:SBRA) Price Target Raised to $18.00

Sabra Health Care REIT (NASDAQ:SBRA) had its price objective upped by Truist Financial from $17.00 to $18.00 in a research note published on Tuesday morning,Benzinga reports. They currently have a hold rating on the real estate investment trust’s stock.

SBRA has been the subject of several other reports. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a report on Tuesday, January 7th. Finally, Mizuho reiterated a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.33.

Sabra Health Care REIT Stock Performance

NASDAQ SBRA opened at $17.33 on Tuesday. The company has a market cap of $4.12 billion, a P/E ratio of 32.70, a P/E/G ratio of 1.97 and a beta of 1.27. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The business’s 50 day moving average price is $16.77 and its 200-day moving average price is $17.67. Sabra Health Care REIT has a fifty-two week low of $13.31 and a fifty-two week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The company had revenue of $182.35 million during the quarter, compared to analysts’ expectations of $178.01 million. Sell-side analysts predict that Sabra Health Care REIT will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.92%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 226.42%.

Institutional Investors Weigh In On Sabra Health Care REIT

Hedge funds have recently made changes to their positions in the stock. VSM Wealth Advisory LLC purchased a new stake in shares of Sabra Health Care REIT during the 4th quarter worth $26,000. Quarry LP purchased a new stake in shares of Sabra Health Care REIT during the 3rd quarter worth $30,000. Assetmark Inc. increased its position in Sabra Health Care REIT by 168.4% during the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 1,231 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Sabra Health Care REIT during the 3rd quarter valued at about $59,000. Finally, GF Fund Management CO. LTD. acquired a new position in Sabra Health Care REIT during the 4th quarter valued at about $74,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.